Patient‐reported neuropathic pain in adolescent and young adult cancer patients

Neuropathic pain, a known complication of cancer and its treatments, negatively impacts quality of life. There are limited data using screening tools to aid in the diagnosis of neuropathic pain in cancer patients. Our primary objective was to determine the proportion of adolescent and young adult cancer patients reporting neuropathic pain on a patient‐completed, neuropathic pain screening tool.

[1]  Deborah Schrag,et al.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Liying Zhang,et al.  The incidence of neuropathic pain in bone metastases patients referred for palliative radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  J. Villoria,et al.  Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross‐sectional study , 2015, European journal of pain.

[4]  G. Tiao,et al.  Vincristine-associated Neurological Morbidity in the Treatment of Hepatoblastoma , 2015, Journal of pediatric hematology/oncology.

[5]  R. Pandey,et al.  Vincristine-induced Neuropathy in Childhood ALL (Acute Lymphoblastic Leukemia) Survivors , 2014, Journal of child neurology.

[6]  M. Bennett,et al.  The role of screening tools in diagnosing neuropathic pain. , 2014, Pain management.

[7]  D. Pei,et al.  Neuropathic pain referrals to a multidisciplinary pediatric cancer pain service. , 2014, Pain management nursing : official journal of the American Society of Pain Management Nurses.

[8]  J. Panepinto,et al.  Neuropathic pain in patients with sickle cell disease , 2014, Pediatric blood & cancer.

[9]  L. Gilchrist,et al.  Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children , 2014, Supportive Care in Cancer.

[10]  L. Lyras,et al.  Cancer-related neuropathic pain in out-patient oncology clinics: a European survey , 2013, BMC Palliative Care.

[11]  M. Hjermstad,et al.  Neuropathic cancer pain: Prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative–Computerised Symptom Assessment study , 2013, Palliative medicine.

[12]  Carmen L. Wilson,et al.  Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study. , 2013, Archives of physical medicine and rehabilitation.

[13]  Rhonda J. Moore,et al.  Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients. , 2013, Cureus.

[14]  S. Friedrichsdorf,et al.  Management of neuropathic pain in children with cancer , 2013, Current opinion in supportive and palliative care.

[15]  B. Onwuteaka-Philipsen,et al.  Decision-making capacity and communication about care of older people during their last three months of life , 2013, BMC Palliative Care.

[16]  Guido Cavaletti,et al.  Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. , 2012, Critical reviews in oncology/hematology.

[17]  L. Gilchrist.  Chemotherapy-induced peripheral neuropathy in pediatric cancer patients. , 2012, Seminars in pediatric neurology.

[18]  M. Hjermstad,et al.  Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review , 2012, PAIN.

[19]  Alec B. O’Connor.  Neuropathic Pain , 2012, PharmacoEconomics.

[20]  M. Relling,et al.  Neuropathic pain during treatment for childhood acute lymphoblastic leukemia , 2011, Pediatric blood & cancer.

[21]  L. Oakes,et al.  Treatment of pain in children after limb-sparing surgery: an institution's 26-year experience. , 2011, Pain management nursing : official journal of the American Society of Pain Management Nurses.

[22]  Blair H. Smith,et al.  NeuPSIG guidelines on neuropathic pain assessment , 2011, PAIN®.

[23]  Ulrika Pöder,et al.  Parents' perceptions of their children's cancer-related symptoms during treatment: a prospective, longitudinal study. , 2010, Journal of pain and symptom management.

[24]  R. Baron,et al.  262 A CROSS‐SECTIONAL SURVEY IN 2100 PATIENTS WITH PAINFUL DIABETIC NEUROPATHY AND POSTHERPETIC NEURALGIA: DIFFERENCES IN DEMOGRAPHIC DATA AND SENSORY SYMPTOMS , 2010 .

[25]  P. Krishnakumar,et al.  Management of pain in leukemic children using the WHO analgesic ladder , 2010, Indian journal of pediatrics.

[26]  Y. Saunthararajah,et al.  Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. , 2010, Journal of the National Medical Association.

[27]  Ralf Baron,et al.  A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms , 2009, PAIN.

[28]  A. Carr,et al.  Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. , 2009, Arthritis and rheumatism.

[29]  Sindhu Ramchandren,et al.  Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia , 2009, Journal of the peripheral nervous system : JPNS.

[30]  S. Bhatnagar,et al.  Pediatric cancer pain management at a regional cancer center: implementation of WHO Analgesic Ladder. , 2009, Middle East journal of anaesthesiology.

[31]  J. Ochoa,et al.  NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES , 2009, Neurology.

[32]  M. Dobratz.  Word Choices of Advanced Cancer Patients: Frequency of Nociceptive and Neuropathic Pain , 2009, The American journal of hospice & palliative care.

[33]  O. Wilder-Smith,et al.  Only half of the chronic pain after thoracic surgery shows a neuropathic component. , 2008, The journal of pain : official journal of the American Pain Society.

[34]  Bernard Laurent,et al.  Prevalence of chronic pain with neuropathic characteristics in the general population , 2008, PAIN.

[35]  R. Dworkin,et al.  The impact of neuropathic pain on health-related quality of life , 2007, Neurology.

[36]  R. Baron,et al.  painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain , 2006, Current medical research and opinion.

[37]  Blair H. Smith,et al.  The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. , 2006, The journal of pain : official journal of the American Pain Society.

[38]  E. Jacob.  Neuropathic Pain in Children With Cancer , 2004, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[39]  G. Oster,et al.  Clinical characteristics and economic costs of patients with painful neuropathic disorders. , 2004, The journal of pain : official journal of the American Pain Society.

[40]  W. Bechstein,et al.  Neurotoxicity of calcineurin inhibitors: impact and clinical management , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[41]  J. Heimans,et al.  Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  N. Hagen,et al.  Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. , 1997, Journal of pain and symptom management.